Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients

NCT00081783 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: Xcellerated T Cells

Sponsor

Xcyte Therapies